ArticlePeerJ2023

Construction and validation of a PANoptosis-related lncRNA signature for predicting prognosis and targeted drug response in thyroid cancer.

Ruowen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.